Core Viewpoint - Betaini is re-entering the high-end beauty device market by revamping the TriPollar brand and establishing an operational team to enhance its product offerings and technology capabilities [2][3]. Group 1: Company Strategy - Betaini is building an operational team for the TriPollar brand, led by Vice General Manager Zhang Mei, and is actively recruiting for various positions related to e-commerce and media [2]. - The collaboration with TriPollar aims to create a synergistic product offering that combines devices, gels, and post-care solutions, covering both home use and medical aesthetics [3]. Group 2: Market Position and Challenges - TriPollar, a high-end home beauty device brand from Israel, has faced challenges, including a recall of over 180,000 units due to temperature control defects and the need for regulatory compliance as a Class III medical device [15][16]. - As of 2025, TriPollar has not made progress in obtaining the necessary Class III medical device certification, which poses a risk of being banned from sale if not achieved by April 2026 [16]. Group 3: Financial Performance - Betaini's market capitalization has significantly declined from a peak of 120 billion yuan to approximately 19.4 billion yuan, with its stock price dropping below the initial offering price [18][19]. - The company's revenue growth has slowed considerably, with net profit halving over the past three years, and a 13.51% year-on-year decline in Q1 2025 [21][22]. Group 4: Investment and R&D - In recent years, Betaini has made strategic investments in the beauty device sector, including a 9.49% stake in Weimai Medical, which is developing high-end medical devices [6]. - The company is also enhancing its independent research and development capabilities, with multiple patents related to radiofrequency beauty devices filed since 2024 [10].